Virstatin
Product Specifications
UNSPSC Description
Virstatin inhibits the pili system synthesis and prevents A. baumannii biofilm formation. Virstatin also inhibits dimerization of the transcriptional activator ToxT[1][2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/virstatin.html
Purity
98.00
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(N(C1=O)CCCC(O)=O)C2=CC=CC3=CC=CC1=C23
Molecular Weight
283.283
References & Citations
[1]Nait Chabane Y, et al. Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii. BMC Microbiol. 2014 Mar 12;14:62.|[2]Shakhnovich EA, et al. Virstatin inhibits dimerization of the transcriptional activator ToxT. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2372-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-127041/Virstatin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-127041/Virstatin-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
88909-96-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6251005-01 0.1 mL
Interleukin 10 Receptor alpha (IL10RA, IL-10RA, IL-10R-A, CDw210a, HIL-10R, IL-10R1, IL10R) (HRP)
Ask
View Details MBS6251005-02 5x 0.1 mL
Interleukin 10 Receptor alpha (IL10RA, IL-10RA, IL-10R-A, CDw210a, HIL-10R, IL-10R1, IL10R) (HRP)
Ask
View Details 
E-CL-H0543-01 24 Tests
Human NOS3/eNOS (Nitric Oxide Synthase 3, Endothelial) CLIA Kit
Ask
View Details 
E-CL-H0543-02 48 Tests
Human NOS3/eNOS (Nitric Oxide Synthase 3, Endothelial) CLIA Kit
Ask
View Details E-CL-H0543-03 96 Tests
Human NOS3/eNOS (Nitric Oxide Synthase 3, Endothelial) CLIA Kit
Ask
View Details PB10046-Dylight594 100 μg
Anti-ACCN1/ASIC2 Antibody Picoband® (Dylight594 Conjugate)
Ask
View Details